Cell therapy landscape in India: Current advances, opportunities, challenges, and future directions
Cell and immunotherapy products are known for targeting the root cause of health ailments and potentially curing cancers and other degenerative indications. The rapid growth in cell therapy products, CRISPR-based gene editing, and stem cell applications in India is changing the face of personalized medicine, putting the country at the forefront of innovative product development. The therapy develops through strong regulatory guidelines and collaborative efforts among academia, industry, and government. However, high costs, less infrastructure, regulatory complexity, and ethics are hurdles in implementing the idea. This review emphasizes the progress made in cell therapy research in India and discusses the challenges as well as the possible strategies for overcoming them.
Authors
- Shailender Gugalavath (ORCID: https://orcid.org/0000-0002-5271-3200)
- Ashis Banerjee
- Deepak Singh (ORCID: https://orcid.org/0000-0002-5841-1764)
- Shubham Verma
- Pratik Saha
- Tannistha Hota
Institutions
- University of Hyderabad (IN)
- Io Therapeutics (United States) (US)
- Laboratoire Procédés, Matériaux et Energie Solaire (FR)
Publication Details
- Journal
- Chemical Biology Letters
- Published
- 2025-03-14
- DOI
- https://doi.org/10.62110/sciencein.cbl.2025.v12.1270
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00